On Tuesday, Zai Lab Limited ADR (NASDAQ: ZLAB) opened higher 3.84% from the last session, before settling in for the closing price of $38.05. Price fluctuations for ZLAB have ranged from $16.01 to $44.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -3.19%. Company’s average yearly earnings per share was noted 47.84% at the time writing. With a float of $109.14 million, this company’s outstanding shares have now reached $110.59 million.
The extent of productivity of a business whose workforce counts for 1869 workers is very important to gauge. In terms of profitability, gross margin is 63.45%, operating margin of -64.09%, and the pretax margin is -60.26%.
Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Zai Lab Limited ADR is 1.31%, while institutional ownership is 47.53%. The most recent insider transaction that took place on Jul 02 ’25, was worth 249,147. In this transaction Chairperson & CEO of this company sold 7,072 shares at a rate of $35.23, taking the stock ownership to the 536,962 shares. Before that another transaction happened on Jul 02 ’25, when Company’s Officer proposed sale 7,072 for $35.23, making the entire transaction worth $249,144.
Zai Lab Limited ADR (ZLAB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.84% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Check out the current performance indicators for Zai Lab Limited ADR (ZLAB). In the past quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach 0.65 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
The latest stats from [Zai Lab Limited ADR, ZLAB] show that its last 5-days average volume of 0.59 million was inferior to 1.0 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 45.60%.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 75.97%, which indicates a significant decrease from 77.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.20 in the past 14 days, which was lower than the 1.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.09, while its 200-day Moving Average is $31.46.
